Welcome to the latest issue of Canadian Securities Exchange Magazine, your source for in-depth stories of entrepreneurs from a wealth of different industries.
Since launching just under a decade ago, the agility of the commercial cannabis industry has been nothing short of remarkable. As the global leader in publicly-listed cannabis securities, the Canadian Securities Exchange is acutely aware of just how nimble the various stakeholders in the industry have had to be in the face of various multifaceted challenges.
In this issue of Canadian Securities Exchange Magazine, we feature executives from six of the most influential CSE-listed cannabis companies, as well as industry experts, who provide their perspectives on how the cannabis industry can maneuver through the current market conditions and where they see the industry going.
The CSE-listed companies featured in this issue include:
Check out the Cannabis Issue of Canadian Securities Exchange Magazine here:
Welcome to the latest issue of Canadian Securities Exchange Magazine, your source for in-depth stories of entrepreneurs from a wealth of different industries. The journey for publicly traded cannabis companies and their investors has often been characterized by change. Since our last cannabis-themed issue in late 2022, the narrative has shifted from rapid expansion to…
MariMed Inc. (CSE:MRMD) and 3 more
MariMed (CSE:MRMD) has captured opportunities across the cannabis value chain with its “seed-to-sale” approach, encompassing flower cultivation, product development, marketing and distribution, and retail operations in key cannabis growth markets in the U.S. Importantly, the company chose a deliberate and evenly paced approach over the lure of rapid expansion to reach this point. The resulting…
MariMed Inc. (CSE:MRMD)
Smart drug delivery systems that deliver medications to specific sites in the human body are on the leading edge of science. This type of biomedical engineering focuses on maximizing drug efficiency and minimizing possible side effects, while reducing the overall amount of medication used and frequency of treatment. Cannabinoids play a crucial role in regulating…
InnoCan Pharma Corporation (CSE:INNO)
